DATE:
TIME:
LINK: https://bit.ly/37mU2p6
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
Filament Health and Psyence Group entered into an into exclusive licensing agreement for Filament’s natural psilocybin drug candidate- Filament was issued a patent by the United States Patent and Trademark Office (USPTO) for the extraction and standardization of natural psilocybin and associated psychedelic compounds, its third patent issued to date
- Filament held a pre-investigational new drug application (PIND) meeting with the United States Food and
Drug Administration (FDA) Division of Psychiatry . During the course of the meeting, Filament and The Division discussed Filament’s natural psychedelic drug candidates, drug development strategy, and long term plans - Filament entered into additional licensing agreements with ATMA Journey Centers and Cybin Therapeutics, each of whom will use Filament’s drug candidates for clinical trials
About
Learn more at www.filament.health and on Twitter, Instagram and LinkedIn.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
CONTACTS:
MEDIA RELATIONS
778.245.9067
anna@filament.health
INVESTOR RELATIONS
347.487.6788
KCSA-investor-relations@filament.health
VIRTUAL INVESTOR CONFERENCES
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
Source: Virtual Investor Conferences
2022 GlobeNewswire, Inc., source